FENC

Conviction 100HealthcareScan · Mon, Aug 10, 2026

FENC$10.92-5.66%

ResistanceSupportVol 14Insider sell

Vol MA14 248.89K

May 11May 28Jun 16Jul 6Jul 23Aug 10

FENNEC PHARMACEUTICALS INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.fennecpharma.com ↗

Price10.92

Change-5.66%

Gap-1.34%

Rel volume13.34×

Avg volume222.74K

Avg $ vol2.36M

SMA 2010.31

SMA 5010.02

SMA 2008.29

Price vs 50+8.96%

Price vs 200+31.76%

MA stackbullish

50/200 cross—

Supertrendup · 9.50

RSI (14)57

MACD hist0.10

MACD crossbull · 2d

Stoch %K / %D67 / 85

ADX (14)18

+DI / −DI28 / 13

RSI divergenceBearish

MACD divergenceBearish

ATR %+5.60%

ADR %5.93%

52w high11.58

52w low5.77

From 52w high-5.66%

Above 52w low+89.25%

New 52w highNo

SqueezeOff

Bollinger width19.98%

%B0.79

Donchian pos67.32%

Donchian high11.66

Donchian low9.40

AVWAP (52w high)11.12

vs AVWAP high-1.82%

AVWAP (52w low)9.22

vs AVWAP low+18.42%

OBV trendDown

Chaikin MF (20)-0.28

Today vs 20d13.34×

Avg vol (14d)248.89K

Avg vol (20d)222.74K

Avg $ vol (20d)2.36M

Market cap—

RS 3m (vs SPY)+62.06%

RS 6m (vs SPY)+37.00%

RS line new highNo

Trend template8/8

Technical rank82.1

1 week+13.87%

1 month+4.10%

3 months+57.58%

6 months+39.29%

1 year+35.32%

YTD+42.19%

P/E-41.30

P/B10.68

P/S9.01

P/FCF-32.25

EPS-0.3400

Div yield—

ROE-25.86%

ROA-13.56%

Debt/Eq0.69

Current6.98

EV/EBITDA-61.78

Gross margin44.79%

Net margin-21.82%

Rev growth-6.09%

EPS growth-2134.17%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value388.08M

Revenue15.11M

Net income201K

Gross profit6.18M

Free cash flow-12.47M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out34.89M

Employees35

ListedMon, Jan 28, 2002

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank82.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance11.28

Support9.12

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in FENC

All disclosures →

No recent disclosed trades by Congress in FENC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in FENC · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
Brughera Marco Maria Director · Stock Option · 2026-06-10	Grant	20K	$174K	2026-06-10	2026-06-10
Cook Jodi A Director · Stock Options · 2026-06-10	Grant	20K	$174K	2026-06-10	2026-06-10
Islam Khalid Director · Stock Option · 2026-06-10	Grant	25K	$218K	2026-06-10	2026-06-10
RALLIS CHRIS A Director · Stock Option · 2026-06-10	Grant	20K	$174K	2026-06-10	2026-06-10
Raykov Rosty Director · Common shares · 2026-06-01	Exercise	15.6K	$38K	2026-06-01	2026-06-02
Raykov Rosty Director · Common shares · 2026-06-01	Sell	9.75K	$94K	2026-06-01	2026-06-02
Raykov Rosty Director · Stock Options · 2026-06-01	Exercise	15.6K	$38K	2026-06-01	2026-06-02
Raykov Rosty Director · Common shares · 2026-05-31	Grant	2.78K	$0	2026-05-31	2026-06-02
Cioffi Christiana Marie Chief Strategy Officer · Common shares · 2026-05-31	Grant	156	$0	2026-05-31	2026-06-01
Hackman Jeffrey S. Chief Executive Officer · Common Shares · 2026-05-31	Grant	1.16K	$0	2026-05-31	2026-06-01

SEC filings

EDGAR filings in FENC · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.